Bioscience Expertise, Training, and Equipment Access
Bioscience Technology is moving so quickly that radical approaches have to be taken to ensure researchers have sustainable access to cutting-edge expertise, equipment and training. The Bioscience Technology Facility is an exemplar which proves...
Vericel: Improving multicellular therapy through advanced manufacturing
Founded in 1989, Vericel (formerly Aastrom Biosciences) is dedicated to the development of patient-specific expanded cellular therapies for use in the treatment of patients with severe diseases and conditions.
The company currently markets two cell...
£45M to advance gene therapy treatment of chronic kidney diseases
The University of Bristol has secured a £45million deal to advance its ground-breaking gene therapy technology for chronic kidney diseases.
The commitment, made by healthcare company Syncona Ltd to Bristol spin-out Purespring Therapeutics, aims to...
Biosimilars – What are the critical regulatory milestones during development and registration?
The ever increasing complexity of regulations and drug approval pathways has converted regulatory intelligence into one of the key assets during any kind of drug development.
This situation is even more pronounced in the case...